| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | SENIOR VICE PRESIDENT | Common shares without par value | 45.1K | $4.87M | $108.00 | 01 Mar 2023 | Direct |
| Axogen, Inc. | Chief Executive Officer | Common Stock | 150K | $3.4M | $22.68 | 04 Dec 2025 | Direct |
| Axogen, Inc. | Chief Executive Officer | Restricted Stock Units | 176K | $3.09M | $17.50 | 25 Mar 2025 | Direct |
| ABBOTT LABORATORIES | SENIOR VICE PRESIDENT | Option (right to buy) | 37.5K | 17 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AXGN | Axogen, Inc. | 04 Dec 2025 | 1 | $0 | 4 | Chief Executive Officer | 05 Dec 2025, 16:06 |
| AXGN | Axogen, Inc. | 25 Mar 2025 | 1 | $0 | 4 | Chief Executive Officer | 26 Mar 2025, 16:48 |
| AXGN | Axogen, Inc. | 09 Aug 2024 | 1 | $0 | 4 | CEO and President, Director | 09 Aug 2024, 16:20 |
| AXGN | Axogen, Inc. | 09 Aug 2024 | 0 | $0 | 3 | CEO and President, Director | 09 Aug 2024, 16:15 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2023 | 2 | -$615K | 4 | SENIOR VICE PRESIDENT | 02 Mar 2023, 18:25 |
| ABT | ABBOTT LABORATORIES | 17 Feb 2023 | 2 | $0 | 4 | SENIOR VICE PRESIDENT | 22 Feb 2023, 17:46 |
| ABT | ABBOTT LABORATORIES | 08 Mar 2022 | 1 | -$468K | 4 | SENIOR VICE PRESIDENT | 10 Mar 2022, 16:25 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2022 | 2 | -$676K | 4 | SENIOR VICE PRESIDENT | 02 Mar 2022, 18:36 |
| ABT | ABBOTT LABORATORIES | 18 Feb 2022 | 2 | $0 | 4 | SENIOR VICE PRESIDENT | 23 Feb 2022, 19:06 |
| ABT | ABBOTT LABORATORIES | 28 Jul 2021 | 3 | -$1.23M | 4 | SENIOR VICE PRESIDENT | 30 Jul 2021, 17:21 |